Ever Source Wealth Advisors, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 118 shares of ARWR stock, worth $2,089. This represents 0.0% of its overall portfolio holdings.
Number of Shares
118
Previous 113
4.42%
Holding current value
$2,089
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ARWR
# of Institutions
305Shares Held
95.9MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$278 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$216 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$197 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$107 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$92.7 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.87B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...